Terms: = Cervical cancer AND TG, Thyroglobulin AND Prognosis
36 results:
1. Metastatic diffuse follicular variant papillary thyroid cancer without cervical lymph node metastasis presenting with symptoms related to hypopituitarism.
Kızılgül M; Bayır Ö; Uçan B; Akhanlı P; Düğer H; Sencar ME; Kertmen H; Yılmazer D; Yazılıtaş D; Saylam G; Korkmaz MH; Çakal E
Einstein (Sao Paulo); 2023; 21():eRC0229. PubMed ID: 37493833
[TBL] [Abstract] [Full Text] [Related]
2. Utility of adjuvant radioactive iodine therapy after reoperation in papillary thyroid carcinoma with cervical lymph node recurrence.
Zhang Y; Zhu X; Fan Q; Huang Q; Tu Y; Jiang L; Zhang Z; Chen J
Jpn J Radiol; 2023 Oct; 41(10):1148-1156. PubMed ID: 37266825
[TBL] [Abstract] [Full Text] [Related]
3. Lymphatic Contrast-enhanced US to Improve the Diagnosis of cervical Lymph Node Metastasis from Thyroid cancer.
Zhang Y; Lu YY; Li W; Zhao JH; Zhang Y; He HY; Li J; Luo YK
Radiology; 2023 May; 307(4):e221265. PubMed ID: 37014243
[TBL] [Abstract] [Full Text] [Related]
4. Surgical resources in advanced thyroid cancer treatment with aerodigestive tract invasion.
Mercader-Cidoncha E; Zaraín-Obrador L; Lasso JM; Simón-Adiego C
Surg Oncol; 2023 Feb; 46():101863. PubMed ID: 36542909
[TBL] [Abstract] [Full Text] [Related]
5. ARP2/3 Regulates Fatty Acid Synthesis by Modulating Lipid Droplets' Motility.
Zhao P; Han H; Wu X; Wu J; Ren Z
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955862
[TBL] [Abstract] [Full Text] [Related]
6. Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Ye L; Hu L; Liu W; Luo Y; Li Z; Ding Z; Hu C; Wang L; Zhu Y; Liu L; Ma X; Kong Y; Huang L
BMC Cancer; 2021 Nov; 21(1):1250. PubMed ID: 34800991
[TBL] [Abstract] [Full Text] [Related]
7. Parapharyngeal Lymph Node Metastasis From Papillary Thyroid Carcinoma.
Masmoudi M; Hasnaoui M; Njima M; Zitouni C; Thabet W; Chebil E; Mighri K
Ear Nose Throat J; 2024 Mar; 103(3):NP164-NP167. PubMed ID: 34558348
[TBL] [Abstract] [Full Text] [Related]
8. [Prediction and investigation of the potential risk factors for the upper mediastinal metastasis of papillary thyroid carcinoma].
Liu Y; Xu SY; Liu K; Wang XL; Liu SY; Xu ZG; Liu J
Zhonghua Zhong Liu Za Zhi; 2021 Apr; 43(4):477-483. PubMed ID: 33902211
[No Abstract] [Full Text] [Related]
9. [Clinicopathological Features of Intrathyroid Thymic Carcinoma].
Zheng ZG; Sun WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):42-46. PubMed ID: 33663661
[TBL] [Abstract] [Full Text] [Related]
10. Long-term Follow-up of a Toddler with Papillary Thyroid Carcinoma: A Case Report with a Literature Review of Patients Under 5 Years of Age.
Öztürk AP; Karakılıç Özturan E; Gün Soysal F; Ünal S; Işık G; Yegen G; Önder S; Yıldız M; Poyrazoğlu Ş; Baş F; Darendeliler F
J Clin Res Pediatr Endocrinol; 2022 Mar; 14(1):119-125. PubMed ID: 33448212
[TBL] [Abstract] [Full Text] [Related]
11. A cutoff thyroglobulin value suggestive of distant metastases in differentiated thyroid cancer patients.
Couto JS; Almeida MFO; Trindade VCG; Marone MMS; Scalissi NM; Cury AN; Ferraz C; Padovani RP
Braz J Med Biol Res; 2020; 53(11):e9781. PubMed ID: 33053096
[TBL] [Abstract] [Full Text] [Related]
12. Association of PIK3CA and MDM2 SNP309 with cervical Squamous Cell Carcinoma in a Philippine Population.
Tantengco OAG; Nakura Y; Yoshimura M; Llamas-Clark EF; Yanagihara I
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2103-2107. PubMed ID: 31350972
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic risk factors for rare oncocytic variantin 101 cases of papillary thyroid carcinoma.
Alagoz E; Okuyucu K; Ince S; Mahmudov S; Ayan A; Demirci İ; Urkan M; Emer O; Cınar A; Deveci S; Gunalp B; Karacalioglu AO; Arslan N
Hell J Nucl Med; 2019; 22(2):116-122. PubMed ID: 31273353
[TBL] [Abstract] [Full Text] [Related]
14. BRAF
Li J; Liu J; Yu X; Bao X; Qian L
Pathol Res Pract; 2018 Nov; 214(11):1892-1897. PubMed ID: 30270103
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract] [Full Text] [Related]
16. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract] [Full Text] [Related]
17. Factors Influencing the Success of the First Radioiodine Therapy for Differentiated Thyroid Carcinoma.
Claimon A; Pusuwan P; Khiewvan B
J Med Assoc Thai; 2017 Feb; 100(2):207-18. PubMed ID: 29916638
[TBL] [Abstract] [Full Text] [Related]
18. Follow-up of differentiated thyroid carcinoma.
Bournaud C; Raverot V
Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S27-33. PubMed ID: 26826480
[TBL] [Abstract] [Full Text] [Related]
19. prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
[TBL] [Abstract] [Full Text] [Related]
20. Carcinoma showing thymus-like differentiation (CASTLE): a case report.
Geraci G; Lo Nigro C; Sciuto A; Modica R; Francesco C; Sciumè C; Attard A; Modica G
Ann Ital Chir; 2013; 84(1):77-80. PubMed ID: 23445782
[TBL] [Abstract] [Full Text] [Related]
[Next]
